4 results on '"Disomma S"'
Search Results
2. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.
- Author
-
Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G, Cecconi M, Choi DJ, Cohen Solal A, Christ M, Masip J, Arrigo M, Nouira S, Ojji D, Peacock F, Richards M, Sato N, Sliwa K, Spinar J, Thiele H, Yilmaz MB, and Januzzi J
- Subjects
- Heart Failure diagnosis, Humans, Shock, Cardiogenic diagnosis, Acute Disease therapy, Critical Care standards, Heart Failure therapy, Practice Guidelines as Topic, Shock, Cardiogenic therapy
- Abstract
Purpose: Acute heart failure (AHF) causes high burden of mortality, morbidity, and repeated hospitalizations worldwide. This guidance paper describes the tailored treatment approaches of different clinical scenarios of AHF and CS, focusing on the needs of professionals working in intensive care settings., Results: Tissue congestion and hypoperfusion are the two leading mechanisms of end-organ injury and dysfunction, which are associated with worse outcome in AHF. Diagnosis of AHF is based on clinical assessment, measurement of natriuretic peptides, and imaging modalities. Simultaneously, emphasis should be given in rapidly identifying the underlying trigger of AHF and assessing severity of AHF, as well as in recognizing end-organ injuries. Early initiation of effective treatment is associated with superior outcomes. Oxygen, diuretics, and vasodilators are the key therapies for the initial treatment of AHF. In case of respiratory distress, non-invasive ventilation with pressure support should be promptly started. In patients with severe forms of AHF with cardiogenic shock (CS), inotropes are recommended to achieve hemodynamic stability and restore tissue perfusion. In refractory CS, when hemodynamic stabilization is not achieved, the use of mechanical support with assist devices should be considered early, before the development of irreversible end-organ injuries., Conclusion: A multidisciplinary approach along the entire patient journey from pre-hospital care to hospital discharge is needed to ensure early recognition, risk stratification, and the benefit of available therapies. Medical management should be planned according to the underlying mechanisms of various clinical scenarios of AHF.
- Published
- 2016
- Full Text
- View/download PDF
3. B-type natriuretic peptide-guided therapy and prognosis in acutely ill patients with pulmonary disease.
- Author
-
Maisel AS and DiSomma S
- Subjects
- Acute Disease, Critical Illness, Diagnosis, Differential, Heart Failure diagnosis, Humans, Monitoring, Physiologic methods, Prognosis, Ventilator Weaning, Critical Care methods, Natriuretic Peptide, Brain blood, Peptide Fragments blood, Respiratory Distress Syndrome blood, Respiratory Distress Syndrome diagnosis, Respiratory Distress Syndrome therapy
- Published
- 2007
- Full Text
- View/download PDF
4. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance
- Author
-
Salvatore DiSomma, Heli Tolppanen, Alexandre Mebazaa, Dike B. Ojji, G. Baksyte, Semir Nouira, Karen Sliwa, A. Cohen Solal, Michael Christ, Dong-Ju Choi, Jindřich Špinar, Maurizio Cecconi, Christian Mueller, Holger Thiele, Naoki Sato, James L. Januzzi, F. Peacock, Josep Masip, Mattia Arrigo, Johan Lassus, Mehmet Yilmaz, Mark Richards, [Mebazaa, A. -- Tolppanen, H. -- Solal, A. Cohen -- Arrigo, M.] INSERM, U942, Paris, France -- [Mebazaa, A. -- Solal, A. Cohen] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France -- [Mebazaa, A.] Hop Lariboisiere, AP HP, Dept Anesthesia & Crit Care, F-75475 Paris, France -- [Tolppanen, H. -- Lassus, J.] Univ Helsinki, Cent Hosp, Heart & Lung Ctr, Helsinki, Finland -- [Mueller, C.] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland -- [Mueller, C.] Univ Basel Hosp, Cardiovasc Res Inst Basel, CH-4031 Basel, Switzerland -- [DiSomma, S.] Univ Roma La Sapienza, St Andrea Hosp, Dept Med Sci & Translat Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy -- [Baksyte, G.] Kaunas Univ Med, Dept Cardiol, Kaunas, Lithuania -- [Cecconi, M.] St Georges Hosp & Med Sch, Anaesthesia & Intens Care, London SW17 0QT, England -- [Choi, D. J.] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea -- [Solal, A. Cohen] Hop Lariboisiere, AP HP, Dept Cardiol, F-75475 Paris, France -- [Christ, M.] Paracelsus Med Univ, Dept Emergency & Intens Care Med, Nurnberg, Germany -- [Masip, J.] Univ Barcelona, Consorci Sanitari Integral, Dept Intens Care Med, Barcelona, Spain -- [Nouira, S.] Fattouma Bourguiba Univ Hosp, Emergency Dept, Monastir, Tunisia -- [Nouira, S.] Fattouma Bourguiba Univ Hosp, Res Unit UR06SP21, Monastir, Tunisia -- [Ojji, D.] Univ Abuja, Teaching Hosp, Dept Med, Cardiol Unit, Gwagwalada, Abuja, Nigeria -- [Peacock, F.] Baylor Coll Med, Dept Emergency Med, Boston, MA USA -- [Richards, M.] Christchurch Hosp, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand -- [Sato, N.] Nippon Med Sch, Musashi Kosugi Hosp, Internal Med Cardiol & Intens Care Unit, Kawasaki, Kanagawa, Japan -- [Sliwa, K.] Univ Cape Town, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, ZA-7925 Cape Town, South Africa -- [Sliwa, K.] Univ Cape Town, IIDMM, ZA-7925 Cape Town, South Africa -- [Spinar, J.] Univ Hosp Brno, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic -- [Thiele, H.] Univ Hosp Schleswig Holstein, Univ Heart Ctr Luebeck, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany -- [Yilmaz, M. B.] Cumhuriyet Univ, Sch Med, Dept Cardiol, Sivas, Turkey -- [Januzzi, J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA, YILMAZ, Mehmet Birhan -- 0000-0002-8169-8628, YILMAZ, MEHMET BIRHAN -- 0000-0002-8169-8628, Cecconi, Maurizio -- 0000-0002-4376-6538, Mebazaa, Alexandre -- 0000-0001-8715-7753, Arrigo, Mattia -- 0000-0003-4028-2869, Nouira, Semir -- 0000-0002-0137-5491, University of Zurich, and Mebazaa, A
- Subjects
Inotrope ,medicine.medical_specialty ,Critical Care ,Shock, Cardiogenic ,610 Medicine & health ,Heart failure ,030204 cardiovascular system & hematology ,heart failure ,cardiogenic shock ,emergency ,treatment ,Critical Care and Intensive Care Medicine ,03 medical and health sciences ,0302 clinical medicine ,Intensive care ,Anesthesiology ,medicine ,Humans ,030212 general & internal medicine ,Myocardial infarction ,Intensive care medicine ,Cardiogenic shock ,Heart Failure ,Respiratory distress ,business.industry ,medicine.disease ,Pulmonary edema ,Treatment ,Acute Disease ,Practice Guidelines as Topic ,Emergency ,10209 Clinic for Cardiology ,business ,2706 Critical Care and Intensive Care Medicine - Abstract
WOS: 000368722000002, PubMed ID: 26370690, Purpose: Acute heart failure (AHF) causes high burden of mortality, morbidity, and repeated hospitalizations worldwide. This guidance paper describes the tailored treatment approaches of different clinical scenarios of AHF and CS, focusing on the needs of professionals working in intensive care settings. Results: Tissue congestion and hypoperfusion are the two leading mechanisms of end-organ injury and dysfunction, which are associated with worse outcome in AHF. Diagnosis of AHF is based on clinical assessment, measurement of natriuretic peptides, and imaging modalities. Simultaneously, emphasis should be given in rapidly identifying the underlying trigger of AHF and assessing severity of AHF, as well as in recognizing end-organ injuries. Early initiation of effective treatment is associated with superior outcomes. Oxygen, diuretics, and vasodilators are the key therapies for the initial treatment of AHF. In case of respiratory distress, non-invasive ventilation with pressure support should be promptly started. In patients with severe forms of AHF with cardiogenic shock (CS), inotropes are recommended to achieve hemodynamic stability and restore tissue perfusion. In refractory CS, when hemodynamic stabilization is not achieved, the use of mechanical support with assist devices should be considered early, before the development of irreversible end-organ injuries. Conclusion: A multidisciplinary approach along the entire patient journey from pre-hospital care to hospital discharge is needed to ensure early recognition, risk stratification, and the benefit of available therapies. Medical management should be planned according to the underlying mechanisms of various clinical scenarios of AHF., Research Council of Lithuania [MIP-049/2015], The work of G. Baksyte was supported by the grant MIP-049/2015 from the Research Council of Lithuania.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.